This article is more than 5 years old. Information may no longer be current.
Onkos Surgical closes a $17.6 million round in Series B funding
Click Here to Manage Email Alerts
Onkos Surgical Inc. announced it has secured a $17.6 million round in Series B Funding, which was led by Canaan Partners along with 1315 Capital and 3-D systems, according to an Onkos press release.
The company will use the funding to expand its sales, marketing and research and development platforms.
“Every day, musculoskeletal oncologists and their patients are faced with clinical challenges that have been overlooked for too long,” Patrick Treacy, chief executive officer and co-founder, said in the release. “We have the portfolio to deliver meaningful innovation with our advanced 3-D printing capabilities, limb restoration technologies, and biologic solutions — all enabled with a unique service and surgical planning platform called uDesign Patient Solutions.”
He added, “The addition of leading investor Canaan Partners to our roster of investors further validates our opportunity to serve this unique and underserved market. The combined intellectual capital and operating experience that Canaan Partners, 1315 Capital and 3-D Systems provides to our leadership team will enable us to scale our business rapidly and efficiently.”
Reference: